Internal Medicine, Cardiovascular Disease · Indianapolis, IN
NPI
1447221981
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5330 E Stop 11 Rd
Indianapolis, IN, 46237
Phone (317) 893-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
2,925 services
Medicare patients, 2024
1,470
Average age 76
Drug cost, 2024
$2.5M
12,898 prescriptions
Company payments, 2025
$9,566
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David O Kovacich was code 99214 (office e&m - established), 631 times for 541 patients. In total David O Kovacich billed 2,925 services in 31 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 631 | 541 | $60.64 | $38K |
| 93306 Echocardiography (TTE/TEE) | Facility | 431 | 425 | $48.02 | $21K |
| 93010 Electrocardiogram | Facility | 301 | 290 | $5.31 | $1,599 |
| 99232 Hospital E&M - Subsequent | Facility | 239 | 87 | $57.50 | $14K |
| 93018 Electrocardiogram | Facility | 165 | 164 | $9.88 | $1,630 |
| 93016 Electrocardiogram | Facility | 164 | 163 | $14.97 | $2,455 |
| 99214 Office E&M - Established | Office | 124 | 109 | $71.51 | $8,867 |
| 78452 Myocardial Perfusion Scan | Facility | 111 | 111 | $54.82 | $6,085 |
| 99291 Critical Care E&M | Facility | 99 | 44 | $155.58 | $15K |
| 99215 Office E&M - Established | Facility | 92 | 84 | $103.91 | $9,560 |
| 99233 Hospital E&M - Subsequent | Facility | 58 | 43 | $83.58 | $4,847 |
| 93325 Echocardiography (TTE/TEE) | Facility | 45 | 45 | $2.04 | $91.79 |
| 93306 Echocardiography (TTE/TEE) | Office | 34 | 34 | $125.40 | $4,264 |
| 93000 Electrocardiogram | Office | 32 | 32 | $10.14 | $325 |
| 99204 Office E&M - New | Facility | 31 | 31 | $85.66 | $2,656 |
By year: 2022 $143K for 2,750 services; 2023 $157K for 2,973 services; 2024 $145K for 2,925 services.
Medicare prescription drug claims, 2024
In 2024, the drug David O Kovacich prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,233 prescriptions and refills. In total David O Kovacich wrote 12,898 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,233 | 3,526 | 416 | $10K |
| Ezetimibe Generic | 849 | 2,362 | 274 | $15K |
| Metoprolol Succinate Generic | 814 | 2,356 | 252 | $12K |
| Amlodipine Besylate Generic | 604 | 1,762 | 185 | $3,718 |
| Carvedilol Generic | 595 | 1,706 | 180 | $4,450 |
| Metoprolol Tartrate Generic | 590 | 1,663 | 184 | $3,903 |
| Eliquis Apixaban | 567 | 1,372 | 162 | $793K |
| Losartan Potassium Generic | 522 | 1,493 | 163 | $4,486 |
| Rosuvastatin Calcium Generic | 512 | 1,432 | 173 | $6,168 |
| Xarelto Rivaroxaban | 451 | 1,032 | 110 | $574K |
| Furosemide Generic | 433 | 1,135 | 147 | $2,206 |
| Clopidogrel Clopidogrel Bisulfate | 403 | 1,166 | 126 | $4,451 |
| Lisinopril Generic | 362 | 1,052 | 110 | $2,899 |
| Spironolactone Generic | 302 | 827 | 99 | $1,841 |
| Potassium Chloride Generic | 300 | 793 | 107 | $5,634 |
Brand drugs: 1,938 claims; generic drugs: 10,960 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David O Kovacich $9,566 ($9,566 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $8,884.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 21 | $8,884 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $200 |
| Novo Nordisk Inc NVO | 4 | $187 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $65.32 |
| Scpharmaceuticals Inc. SCPH | 2 | $58.91 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $51.09 |
| Pfizer Inc. PFE | 2 | $36.55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33.26 |
| BridgeBio Pharma, Inc. BBIO | 1 | $18.35 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $16.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.